podophyllotoxin has been researched along with Myeloproliferative Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allard, A; Chompret, A; de Vathaire, F; Diallo, I; Haddy, N; Lassalle, M; Le Deley, MC; Lefkopoulos, D; Quiniou, E; Rubino, C; Samsaldin, A | 1 |
| Arakawa, S; Esumi, N; Imashuku, S; Todo, S | 1 |
2 other study(ies) available for podophyllotoxin and Myeloproliferative Disorders
| Article | Year |
|---|---|
Role of radiation dose in the risk of secondary leukemia after a solid tumor in childhood treated between 1980 and 1999.
Topics: Adolescent; Algorithms; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Bone Marrow; Case-Control Studies; Child; Child, Preschool; Dose-Response Relationship, Radiation; Female; France; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Likelihood Functions; Male; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Risk Assessment | 2010 |
[Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Leukemia; Lymphoma; Male; Myeloproliferative Disorders; Podophyllotoxin | 1986 |